Hormone Replacement Therapy andOvarian Cancers

Czech version

Authors: L. Ševčík; Jaroslav Klát; Peter Koliba
Authors‘ workplace: Porodnicko-gynekologická klinika, FNsP Ostrava, přednosta MUDr. Peter Koliba, CSc.
Published in: Ceska Gynekol 2002; (2): 55-58
Category:

Overview

Objective:
Analysis of risk and protective factors and hormone replacement therapy in the aethio-logy and pathogenesis of ovarian cancer. The role of hormone replacement therapy in the com-plex treatment in women with ovarian cancer is discussed.Design: Reviewed article.Setting: Department of Obstetrics and Gynaecology, University Hospital Ostrava.Methods: Analysis of epidemiological studies.Conclusion: The role of hormone replacement therapy as a risk factor of ovarian cancer has notbeen confirmed. Hormone replacement therapy as a part of supportive and symptomatic therapyhas been acceptable in a great deal of patients with ovarian cancer.

Key words:
hormone replacement therapy, ovarian cancer

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.